BACKGROUND: The aim of the present study was to examine the early outcome in patients undergoing intestinal resection for Crohn's disease (CD) while they are receiving perioperative immunosuppressive medication. METHODS: We reviewed patients with CD undergoing intestinal surgery from 1999 to 2007. Demographics and relevant perioperative information, including medication, were extracted from patient charts. Statistical analysis was performed using Fisher's exact test. RESULTS: During the course of the study period 112 with Crohn's disease underwent intestinal resection, and 69 of them were receiving perioperative medication (47, corticosteroids; 39, immunomodulators; and 17, anti-tumor necrosis factor-alpha antibodies). There were no deaths. Median blood loss was 137 ml. Twenty-two of the patients using perioperative medication (32%) experienced complications, 10 of which were major. The major complications occurred in 3 of the 43 patients (7%) who were not receiving perioperative medications, in 5 of 38 patients (13%) who were receiving one drug, 4 of 28 patients (14%) receiving two drugs, and 1 of 3 patients (33%) receiving three drugs. Thus the occurrence of major complications was not significantly greater in patients receiving perioperative medication. Risk factors for a major complication were intraoperative blood loss >400 ml (P < 0.003) and emergency surgery (P < 0.005). CONCLUSIONS: The occurrence of complications in Crohn's disease patients undergoing intestinal resection was not associated with the use of immunosuppressive medication. However, emergency surgery and blood loss were risk factors, and reflect the difficulty of surgery in this group of patients.
BACKGROUND: The aim of the present study was to examine the early outcome in patients undergoing intestinal resection for Crohn's disease (CD) while they are receiving perioperative immunosuppressive medication. METHODS: We reviewed patients with CD undergoing intestinal surgery from 1999 to 2007. Demographics and relevant perioperative information, including medication, were extracted from patient charts. Statistical analysis was performed using Fisher's exact test. RESULTS: During the course of the study period 112 with Crohn's disease underwent intestinal resection, and 69 of them were receiving perioperative medication (47, corticosteroids; 39, immunomodulators; and 17, anti-tumornecrosis factor-alpha antibodies). There were no deaths. Median blood loss was 137 ml. Twenty-two of the patients using perioperative medication (32%) experienced complications, 10 of which were major. The major complications occurred in 3 of the 43 patients (7%) who were not receiving perioperative medications, in 5 of 38 patients (13%) who were receiving one drug, 4 of 28 patients (14%) receiving two drugs, and 1 of 3 patients (33%) receiving three drugs. Thus the occurrence of major complications was not significantly greater in patients receiving perioperative medication. Risk factors for a major complication were intraoperative blood loss >400 ml (P < 0.003) and emergency surgery (P < 0.005). CONCLUSIONS: The occurrence of complications in Crohn's diseasepatients undergoing intestinal resection was not associated with the use of immunosuppressive medication. However, emergency surgery and blood loss were risk factors, and reflect the difficulty of surgery in this group of patients.
Authors: Sebastiaan W Polle; Jan Wind; Dirk T Ubbink; Daan W Hommes; Dirk J Gouma; Willem A Bemelman Journal: Dig Surg Date: 2006-12-12 Impact factor: 2.588
Authors: Chelliah R Selvasekar; Robert R Cima; David W Larson; Eric J Dozois; Jeffrey R Harrington; William S Harmsen; Edward V Loftus; William J Sandborn; Bruce G Wolff; John H Pemberton Journal: J Am Coll Surg Date: 2007-05 Impact factor: 6.113
Authors: Stefanie J Schluender; Andrew Ippoliti; Marla Dubinsky; Eric A Vasiliauskas; Konstantinos A Papadakis; Ling Mei; Stephan R Targan; Phillip R Fleshner Journal: Dis Colon Rectum Date: 2007-11 Impact factor: 4.585
Authors: Jean Frédéric Colombel; Edward V Loftus; William J Tremaine; John H Pemberton; Bruce G Wolff; Tonia Young-Fadok; William S Harmsen; Cathy D Schleck; William J Sandborn Journal: Am J Gastroenterol Date: 2004-05 Impact factor: 10.864
Authors: Miguel Regueiro; Sandra El-Hachem; Kevin E Kip; Wolfgang Schraut; Leonard Baidoo; Andrew Watson; Jason Swoger; Marc Schwartz; Arthur Barrie; Marilyn Pesci; David Binion Journal: Dig Dis Sci Date: 2011-06-17 Impact factor: 3.199
Authors: Jan-Hendrik Egberts; Antje Stroeh; Ibrahim Alkatout; Freya A Goumas; Phillipp A Brand; Clemens Schafmayer; Thomas Becker; Bodo Schniewind Journal: Int J Colorectal Dis Date: 2011-04-28 Impact factor: 2.571
Authors: Chaya Shwaartz; Adam C Fields; Maximiliano Sobrero; Brian D Cohen; Celia M Divino Journal: J Gastrointest Surg Date: 2016-07-12 Impact factor: 3.452